Comparative Pharmacology
Head-to-head clinical analysis: DEXASPORIN versus HI COR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXASPORIN versus HI COR.
DEXASPORIN vs HI-COR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dexasporin is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It binds to the glucocorticoid receptor, leading to modulation of gene expression and inhibition of pro-inflammatory mediators such as prostaglandins and leukotrienes.
Corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production, inhibits phospholipase A2, and reduces prostaglandin and leukotriene synthesis.
1 to 2 mg/kg intramuscular or intravenous every 8 hours.
0.1-0.2 mg/kg intravenously once.
None Documented
None Documented
3-4 hours (prolonged to 10-15 hours in renal impairment; monitor CrCl <30 mL/min)
Terminal elimination half-life is 2-4 hours. Clinical context: Short half-life requires frequent dosing for sustained effect; accumulation possible in renal impairment.
Renal excretion (80-90% unchanged), biliary/fecal (10-20%)
Renal excretion of unchanged drug and metabolites accounts for approximately 70-80% of elimination, with biliary/fecal excretion contributing 20-30%.
Category C
Category C
Corticosteroid/Antibiotic Combination
Corticosteroid